Ultra high-cost drugs
June 20, 2022
10 Minute Read
- Ultra high-cost drugs (UHCDs) are expensive, potentially durable, or curative therapies currently approved to treat conditions that are orphan and rare disease.
- UHCDs are relatively new pharmaceutical products in the market, but their presence will almost certainly increase dramatically over the next decade.
- UHCDs are disrupting three elements of healthcare: care delivery, generation of clinical evidence, and cost/payment models.